The Valley Desk

Clinical trial reportArthritis & rheumatology (Hoboken, N.J.)Published

Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double-Blind, Placebo-Controlled APEX Study

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Arthritis & rheumatology (Hoboken, N.J.)
Published
PubMed ID
42901870
Added to directory
Source checked

Report a correction or request removal